Difference between the cognitive and control ability and the responsibility in forensic psychiatry evaluation / 法医学杂志

OBJECTIVE@#To analyze the difference between the cognitive and control ability and the responsibility in forensic psychiatry evaluation.@*METHODS@#To compare the results of the responsibility evaluation from 2001.1 to 2006.10 (the first period) with that of the cognitive and control ability evaluation from 2006.11 to 2010.10 (the second period). The admissibility opinions on court judgment and evaluation were investigated by return visit. The legal professions' opinions on forensic psychiatric issues from the police office, the procuratorate, the court, and the judiciary were investigated.@*RESULTS@#There was no significant difference of the criminal types between two periods (P > 0.05). There was significant difference of the diagnostic types between two periods (P < 0.05). The proportion of normal range and part loss of the cognitive and control ability in the second period were higher than that in the first period, but the proportion of complete loss of the cognitive and control ability in the second period was lower than that in the first period (P < 0.05). Among the legal professions, 70.5% of them thought that "the evaluation of cognitive and control ability" was different from "the evaluation of criminal responsibility" and 94.9% of them thought that "to confirm the influence of the forensic psychiatric evaluation of mental disorder on the crime behavior" or "to assess of cognitive and control ability" met requirements of normative judicial expertise.@*CONCLUSION@#The evaluation of cognitive and control ability is more aligned with legal requirements and behavioral norms of own subject than the evaluation of responsibility.

An examination of the self-reported scale of brief psychopathological symptoms to detect malingering in forensic psychiatric subjects / 法医学杂志

OBJECTIVE@#To examine the self-reported scale of brief psychopathological symptoms (SBPS) to detect malingering in forensic psychiatric cases.@*METHODS@#Two hundred and six cases with different types of psychiatric problems were tested by SBPS. All cases were separately evaluated by two experts.@*RESULTS@#About 34.5% cases (71/206) were classified as malingering by the cut-off 13 scores of SBPS. Compared with expert's evaluation, SBPS showed a false negative rate of 19.8% and a false positive rate of 1.7%, respectively, with a total accuracy rate of 90.8%. Cases involved in compensations including working injury and traffic accidence showed the highest rate of malingering (51%).@*CONCLUSION@#SBPS is useful for detecting malingering psychopathological symptoms.

Advances of clinical studies of acupuncture and moxibustion for treatment of rheumatoid arthritis / 中国针灸

<p><b>OBJECTIVE</b>To summarize recent development of studies on acupuncture and moxibustion for prevention and treatment of rheumatoid arthritis, so as to provide a basis and thinking for clinical scientific studies.</p><p><b>METHODS</b>More than 60 papers about clinical and experimental studies were reviewed, choosing clinically commonly-used acupoints and introducing mainly different therapeutic methods.</p><p><b>RESULTS</b>Acupuncture and moxibustion can prevent and cure rheumatoid arthritis with outstanding results.</p><p><b>CONCLUSION</b>Acupuncture and moxibustion have vast vistas for treatment of rheumatoid arthritis.</p>

Comparative study of electro-acupuncture and maprotiline in treating depression / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To compare the effect of electro-acupuncture (EA) and maprotiline (Map) in treating depression.</p><p><b>METHODS</b>Thirty patients of depression were treated with EA and 31 patients with Map orally taken respectively. The therapeutic effect and side-effect were evaluated by measurement of Hamilton Depression Rating Scale (HAMD), Self-Rating Scale for Depression (SDS), Self-Rating Scale for Anxiety (SAS), Clinical Global Impression Scale (CGI) and Asberg Rating Scale for side-effects (ARS) before treatment and on the day 14, 28 and 42 of the therapeutic course.</p><p><b>RESULTS</b>After treatment, the scores of HAMD and SDS lowered significantly (P < 0.01) than before treatment, and with insignificant difference between the group (P > 0.05). For patients with somatic syndrome, the HAMD score decrease rate was obviously higher in the Map group than that in the EA group. However, for the patients with anxiety somatization syndrome, the score of SAS, ARS in the EA group were significantly lower than those in the Map group (P < 0.05). Moreover, the efficacy index was higher in the EA group (P < 0.01).</p><p><b>CONCLUSION</b>Both EA and Map are effective in treating depression.</p>